Medical devices, healthcare technology and the business of care
510(k) clearance · K253493

Dentis SQ-SL AXEL Fixture

DENTIS CO. ,LTD · Decision date Mar 4, 2026

FDA DECISIONK253493

What did the FDA decide?

FDA records K253493 as a 510(k) premarket notification, with a decision dated Mar 4, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Mar 4, 2026

FDA source record

Regulatory record facts

Identifier
K253493
Regulatory pathway
510(k) premarket notification
Product code
DZE
Decision code
SESE
Decision date
Mar 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, Endosseous, Root-Form.

Product code
DZE
FDA device class
2

FDA decision timeline

  1. K253493 received

    Application receipt date recorded by FDA.

  2. K253493 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DZE

Product / regulatory recordCompanyPathwayDecision dateSource
Alpha Bio Tec , Ltd.510(k) clearanceOct 22, 2026FDA
Paragon Implant Mfg., LLC510(k) clearanceSep 17, 2026FDA
Zeros Co., Ltd.510(k) clearanceAug 19, 2026FDA
Uniqa Dental, Ltd.510(k) clearanceJun 25, 2026FDA
A.B. Dental Devices , Ltd.510(k) clearanceJun 18, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

DENTIS CO. ,LTD

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Dalseo-Gu

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records